NUCLEOLIN and cancer: Subsequently, classical and innovative cell-free and cell-based assays were used to demonstrate oridonin to be an effective Nucleolin modulator in two human cancer-derived cell lines, Jurkat (leukemia T cell line) and HeLa (cervical cancer cell line).